EMBECTA CORP. Shareholders' Equity
EMBECTA CORP. (EMBC) had Shareholders' Equity of -$612.70 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent -$612.70M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$626.10M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$613.10M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$650.60M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$612.70M 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$626.10M 10-Q · filed 2026-08-07 |
| 2025-12-31 | -$613.10M 10-Q · filed 2026-05-05 |
| 2025-09-30 | -$650.60M 10-Q · filed 2026-08-07 |
| 2025-06-30 | -$669.60M 10-Q · filed 2026-08-07 |
| 2025-03-31 | -$736.20M 10-Q · filed 2026-08-07 |
| 2024-12-31 | -$768.80M 10-Q · filed 2026-05-05 |
| 2024-09-30 | -$738.30M 10-Q · filed 2026-08-07 |
| 2024-06-30 | -$763.70M 10-Q · filed 2025-08-08 |
| 2024-03-31 | -$769.60M 10-Q · filed 2025-08-08 |
| 2023-12-31 | -$793.50M 10-Q · filed 2025-05-09 |
| 2023-09-30 | -$821.70M 10-K · filed 2025-11-25 |
| 2023-06-30 | -$809.40M 10-Q · filed 2024-08-09 |
| 2023-03-31 | -$822.60M 10-Q · filed 2024-08-09 |
| 2022-12-31 | -$836.10M 10-Q · filed 2024-05-09 |
| 2022-09-30 | -$891.40M 10-K · filed 2025-11-25 |
| 2022-06-30 | -$847.60M 10-Q · filed 2023-08-08 |
| 2022-03-31 | -$967.50M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $550.50M 10-Q · filed 2023-05-12 |
| 2021-09-30 | $594.30M 10-K · filed 2024-12-11 |
| 2021-06-30 | $576.70M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $580.70M 10-Q · filed 2022-08-15 |
| 2020-12-31 | $585.80M 10-Q · filed 2022-05-13 |
| 2020-09-30 | $572.20M 10-K · filed 2023-11-29 |
| 2019-09-30 | $577.10M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |